Staff View: Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries

Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries

BACKGROUND: Access to affordable inhaled medicines for chronic respiratory diseases (CRDs) is severely limited in low-and middle-income countries (LMICs), causing avoidable morbidity and mortality. The Inter-national Union Against Tuberculosis and Lung Disease convened a stakeholder meeting on this...

Full description

Saved in:

Bibliographic Details
Main Authors:	Stolbrink, M., Chinouya, M. J., Jayasooriya, S., Nightingale, R., Evans-Hill, L., Allan, K., Allen, H., Balen, J., Beacon, T., Bissell, K., Chakaya, J., Chiang, C-y., Cohen, M., Devereux, G., El Sony, A., Halpin, D. M. G., Hurst, J. R., Kiprop, C., Lawson, A., Mace, C., Makhanu, A., Makokha, P., Masekela, R., Meme, H., Khoo, Ee Ming, Nantanda, R., Pasternak, S., Perrin, C., Reddel, H., Rylance, S., Schweikert, P., Were, C., Williams, S., Winders, T., Yorgancioglu, A., Marks, G. B., Mortimer, K.
Format:	Article
Published:	INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D) 2022
Subjects:	R Medicine
Online Access:	http://eprints.um.edu.my/46215/ https://doi.org/10.5588/ijtld.22.0270
Tags:	Add Tag No Tags, Be the first to tag this record!

id	my.um.eprints.46215
record_format	eprints
spelling	my.um.eprints.462152024-08-05T08:26:19Z http://eprints.um.edu.my/46215/ Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries Stolbrink, M. Chinouya, M. J. Jayasooriya, S. Nightingale, R. Evans-Hill, L. Allan, K. Allen, H. Balen, J. Beacon, T. Bissell, K. Chakaya, J. Chiang, C-y. Cohen, M. Devereux, G. El Sony, A. Halpin, D. M. G. Hurst, J. R. Kiprop, C. Lawson, A. Mace, C. Makhanu, A. Makokha, P. Masekela, R. Meme, H. Khoo, Ee Ming Nantanda, R. Pasternak, S. Perrin, C. Reddel, H. Rylance, S. Schweikert, P. Were, C. Williams, S. Winders, T. Yorgancioglu, A. Marks, G. B. Mortimer, K. R Medicine BACKGROUND: Access to affordable inhaled medicines for chronic respiratory diseases (CRDs) is severely limited in low-and middle-income countries (LMICs), causing avoidable morbidity and mortality. The Inter-national Union Against Tuberculosis and Lung Disease convened a stakeholder meeting on this topic in February 2022.METHODS: Focused group discussions were informed by literature and presentations summarising experiences of obtaining inhaled medicines in LMICs. The virtual meeting was moderated using a topic guide around barriers and solutions to improve access. The thematic framework approach was used for analysis.RESULTS: A total of 58 key stakeholders, including patients, healthcare practitioners, members of national and international organisations, industry and WHO representatives attended the meeting. There were 20 pre-meeting material submissions. The main barriers identified were 1) low awareness of CRDs; 2) limited data on CRD burden and treatments in LMICs; 3) ineffective procurement and distribution networks; and 4) poor communication of the needs of people with CRDs. Solutions discussed were 1) generation of data to inform policy and practice; 2) capacity building; 3) improved procurement mechanisms; 4) strengthened advocacy practices; and 5) a World Health Assembly Resolution.CONCLUSION: There are opportunities to achieve improved access to affordable, quality-assured inhaled medicines in LMICs through coordinated, multi -stake-holder, collaborative efforts. INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D) 2022-11-01 Article PeerReviewed Stolbrink, M. and Chinouya, M. J. and Jayasooriya, S. and Nightingale, R. and Evans-Hill, L. and Allan, K. and Allen, H. and Balen, J. and Beacon, T. and Bissell, K. and Chakaya, J. and Chiang, C-y. and Cohen, M. and Devereux, G. and El Sony, A. and Halpin, D. M. G. and Hurst, J. R. and Kiprop, C. and Lawson, A. and Mace, C. and Makhanu, A. and Makokha, P. and Masekela, R. and Meme, H. and Khoo, Ee Ming and Nantanda, R. and Pasternak, S. and Perrin, C. and Reddel, H. and Rylance, S. and Schweikert, P. and Were, C. and Williams, S. and Winders, T. and Yorgancioglu, A. and Marks, G. B. and Mortimer, K. (2022) Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 26 (11). pp. 1023-1032. ISSN 1815-7920, DOI https://doi.org/10.5588/ijtld.22.0270 <https://doi.org/10.5588/ijtld.22.0270>. https://doi.org/10.5588/ijtld.22.0270 10.5588/ijtld.22.0270
institution	Universiti Malaya
building	UM Library
collection	Institutional Repository
continent	Asia
country	Malaysia
content_provider	Universiti Malaya
content_source	UM Research Repository
url_provider	http://eprints.um.edu.my/
topic	R Medicine
spellingShingle	R Medicine Stolbrink, M. Chinouya, M. J. Jayasooriya, S. Nightingale, R. Evans-Hill, L. Allan, K. Allen, H. Balen, J. Beacon, T. Bissell, K. Chakaya, J. Chiang, C-y. Cohen, M. Devereux, G. El Sony, A. Halpin, D. M. G. Hurst, J. R. Kiprop, C. Lawson, A. Mace, C. Makhanu, A. Makokha, P. Masekela, R. Meme, H. Khoo, Ee Ming Nantanda, R. Pasternak, S. Perrin, C. Reddel, H. Rylance, S. Schweikert, P. Were, C. Williams, S. Winders, T. Yorgancioglu, A. Marks, G. B. Mortimer, K. Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries
description	BACKGROUND: Access to affordable inhaled medicines for chronic respiratory diseases (CRDs) is severely limited in low-and middle-income countries (LMICs), causing avoidable morbidity and mortality. The Inter-national Union Against Tuberculosis and Lung Disease convened a stakeholder meeting on this topic in February 2022.METHODS: Focused group discussions were informed by literature and presentations summarising experiences of obtaining inhaled medicines in LMICs. The virtual meeting was moderated using a topic guide around barriers and solutions to improve access. The thematic framework approach was used for analysis.RESULTS: A total of 58 key stakeholders, including patients, healthcare practitioners, members of national and international organisations, industry and WHO representatives attended the meeting. There were 20 pre-meeting material submissions. The main barriers identified were 1) low awareness of CRDs; 2) limited data on CRD burden and treatments in LMICs; 3) ineffective procurement and distribution networks; and 4) poor communication of the needs of people with CRDs. Solutions discussed were 1) generation of data to inform policy and practice; 2) capacity building; 3) improved procurement mechanisms; 4) strengthened advocacy practices; and 5) a World Health Assembly Resolution.CONCLUSION: There are opportunities to achieve improved access to affordable, quality-assured inhaled medicines in LMICs through coordinated, multi -stake-holder, collaborative efforts.
format	Article
author	Stolbrink, M. Chinouya, M. J. Jayasooriya, S. Nightingale, R. Evans-Hill, L. Allan, K. Allen, H. Balen, J. Beacon, T. Bissell, K. Chakaya, J. Chiang, C-y. Cohen, M. Devereux, G. El Sony, A. Halpin, D. M. G. Hurst, J. R. Kiprop, C. Lawson, A. Mace, C. Makhanu, A. Makokha, P. Masekela, R. Meme, H. Khoo, Ee Ming Nantanda, R. Pasternak, S. Perrin, C. Reddel, H. Rylance, S. Schweikert, P. Were, C. Williams, S. Winders, T. Yorgancioglu, A. Marks, G. B. Mortimer, K.
author_facet	Stolbrink, M. Chinouya, M. J. Jayasooriya, S. Nightingale, R. Evans-Hill, L. Allan, K. Allen, H. Balen, J. Beacon, T. Bissell, K. Chakaya, J. Chiang, C-y. Cohen, M. Devereux, G. El Sony, A. Halpin, D. M. G. Hurst, J. R. Kiprop, C. Lawson, A. Mace, C. Makhanu, A. Makokha, P. Masekela, R. Meme, H. Khoo, Ee Ming Nantanda, R. Pasternak, S. Perrin, C. Reddel, H. Rylance, S. Schweikert, P. Were, C. Williams, S. Winders, T. Yorgancioglu, A. Marks, G. B. Mortimer, K.
author_sort	Stolbrink, M.
title	Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries
title_short	Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries
title_full	Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries
title_fullStr	Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries
title_full_unstemmed	Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries
title_sort	improving access to affordable quality-assured inhaled medicines in low- and middle-income countries
publisher	INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
publishDate	2022
url	http://eprints.um.edu.my/46215/ https://doi.org/10.5588/ijtld.22.0270
_version_	1806688799466455040
score	13.211869

Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries

Similar Items